Metropolitan Life Insurance Company (MetLife)’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,849
| Closed | -$8.12K | – | 2480 |
|
|
2023
Q1 | $8.12K | Buy |
2,849
+771
| +37% | +$2.2K | ﹤0.01% | 2224 |
|
|
2022
Q4 | $15.1K | Hold |
2,078
| – | – | ﹤0.01% | 2129 |
|
|
2022
Q3 | $16.8K | Buy |
+2,078
| New | +$16.8K | ﹤0.01% | 2105 |
|
|
2022
Q2 | – | Sell |
-1,783
| Closed | -$42.2K | – | 2393 |
|
|
2022
Q1 | $42.2K | Sell |
1,783
-5,446
| -75% | -$129K | ﹤0.01% | 1690 |
|
|
2021
Q4 | $128K | Hold |
7,229
| – | – | ﹤0.01% | 2332 |
|
|
2021
Q3 | $204K | Buy |
+7,229
| New | +$204K | ﹤0.01% | 2052 |
|
|
2020
Q3 | – | Sell |
-4,328
| Closed | -$79.2K | – | 2576 |
|
|
2020
Q2 | $79.2K | Buy |
4,328
+3,313
| +326% | +$60.6K | ﹤0.01% | 2384 |
|
|
2020
Q1 | $12.1K | Buy |
+1,015
| New | +$12.1K | ﹤0.01% | 2481 |
|